Jeffrey C. Lombardo, PharmD, BCOP

home / authors / jeffrey-c-lombardo-pharmd-bcop

Articles

Challenges and Innovations in the Manufacture of Hazardous Drugs

Challenges and Innovations in the Manufacture of Hazardous Drugs

Jeffrey C. Lombardo, PharmD, BCOP
January 11th 2019

USP General Chapter , which was published by the United States Pharmacopeial Convention and updated most recently in December 2017, sets forth guidelines for the handling of hazardous drugs in the health care setting with the goal of promoting safety for patients and health care workers.

Read More

Evaluating Effective Protective Measures for Minimizing the Risk of Exposure to Hazardous Drugs

Evaluating Effective Protective Measures for Minimizing the Risk of Exposure to Hazardous Drugs

Jeffrey C. Lombardo, PharmD, BCOP;Rachel L. Brown, PharmD, MPH
May 24th 2018

Read More

Evaluating Effective Protective Measures for Minimizing the Risk of Exposure to Hazardous Drugs

Evaluating Effective Protective Measures for Minimizing the Risk of Exposure to Hazardous Drugs

Jeffrey C. Lombardo, PharmD, BCOP;Rachel L. Brown, PharmD, MPH
February 22nd 2018

Continuing education activity featured in the March 2018 edition of Pharmacy Times.

Read More

Latest Updated Articles

Sweden - March 23, 2015: McDonald's yellow and red logo advertising sign placed on a pole with against clear blue sky
Published: October 23rd 2024 | Updated: October 24th 2024
What to Know About E Coli Outbreak Linked to McDonald’s Quarter Pounders
10 Pharmacy Quotes That Will Make You Rethink the Profession
Published: January 18th 2016 | Updated: October 18th 2024
10 Pharmacy Quotes That Will Make You Rethink the Profession
Gabapentin Differs From Pregabalin in Several Key Ways
Published: September 22nd 2015 | Updated: October 14th 2024
Gabapentin Differs From Pregabalin in Several Key Ways
Small Cell Lung Cancer Cells: These small, round cells in the lungs divide rapidly and are known for early metastasis, resulting in highly aggressive cancer.
Published: December 17th 2024 | Updated: December 21st 2024
Sacituzumab Govitecan-hziy Receives FDA Breakthrough Therapy Designation for Extensive-Stage Small Cell Lung Cancer Treatment
Toddler boy has Cold or Flu or influenza or asthma or pneumonia disease and need nebulizations,Sick boy rest on patient bed in hospital and has inhalation therapy by the mask of inhaler.Sick - Image credit: Bonn | stock.adobe.com
Published: December 19th 2024 | Updated: December 21st 2024
FDA Accepts Biologics License Application for Clesrovimab to Protect Infants from RSV Infection
ASHP Midyear: Pharmacists Play Key Role in Addressing Depression in Women Through Medication Management
Published: December 13th 2024 | Updated: December 21st 2024
ASHP Midyear: Pharmacists Play Key Role in Addressing Depression in Women Through Medication Management